Ultragenyx Pharmaceutical OverviewUltragenyx Pharmaceutical Income Tax
Income tax expense trends for RARE.
Quarterly Income Tax
$1.00M
↓ 23.66% YoY
As of Mar 2026
Annual Income Tax (TTM)
$3.82M
↑ 2838.46% YoY
Trailing 12 months ending Mar 2026
Average Income Tax (Comparison Companies)
Income Tax History
Income Tax Comparison
Annual Income Tax Growth Rate (%)
Loading...
Annual Income Tax Growth (Absolute)
Loading...